Cox regression and Kaplan–Meier analysis showed that patients with higher XCR1 expression were associated with better prognosis; therefore, XCR1 may be a potential prognostic biomarker for ccRCC. Here, XCR1 is linked to nonpapillary renal cell carcinoma.